Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2019

02.07.2019 | Research Article

Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge

verfasst von: Louai Alsaloumi, Abdikarim Abdi, Özgür Tosun, Bilgen Başgut

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Background Pharmacogenomics is a branch of biotechnological science integrating medicine, pharmacology, and genomics techniques. Moreover, it focuses on creating drug therapies in order to analyze genetic differences in patients causing various responses to a single therapeutic regimen. Objective This cross sectional study aimed to examine the attitude, knowledge and adoption among pharmacists in North Cyprus and the most appropriate method to improve education among them. Setting Community pharmacy setting. Method A total of 103 out of 140 pharmacists responded to a pre-tested and validated questionnaire consisting of 25 items during July through September 2016. Main outcome measure Pharmacists attitude, knowledge and adoption towards pharmacogenomic tests. Result Data showed that most of the pharmacists in North Cyprus had positive attitude and knowledge scores with mean value of 28.3 ± 5.3 (out of 40) and 6.9 ± 0.8 (out of 10) respectively, further findings showed that there is a significant difference among age groups in their total attitude score (p < 0.05). Conclusion Even though pharmacogenomics is a field promising a variety of benefits, it is vital to implement it in clinical settings in order to improve outcomes. Our findings highlight the necessity for more education on the availability and interpretation of pharmacogenomics tests.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat De Denus S, Letarte N, Hurlimann T, Lambert J-P, Lavoie A, Robb L, et al. An evaluation of pharmacists’ expectations towards pharmacogenomics. Pharmacogenomics. 2013;14(2):165–75.PubMedCrossRef De Denus S, Letarte N, Hurlimann T, Lambert J-P, Lavoie A, Robb L, et al. An evaluation of pharmacists’ expectations towards pharmacogenomics. Pharmacogenomics. 2013;14(2):165–75.PubMedCrossRef
2.
Zurück zum Zitat Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal MR, et al. Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics. 2014;15(9):1223–34.PubMedCrossRef Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal MR, et al. Personalized pharmacogenomics profiling using whole-genome sequencing. Pharmacogenomics. 2014;15(9):1223–34.PubMedCrossRef
3.
Zurück zum Zitat Salleh MZ, Teh LK, Lee LS, Ismet RI, Patowary A, Joshi K, et al. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine. PLoS ONE. 2013;8(8):e71554.PubMedPubMedCentralCrossRef Salleh MZ, Teh LK, Lee LS, Ismet RI, Patowary A, Joshi K, et al. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine. PLoS ONE. 2013;8(8):e71554.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Bannur Z, Bahaman S, Salleh M, Kek TL. Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. Int Med J Malays. 2014;13(1):41–50. Bannur Z, Bahaman S, Salleh M, Kek TL. Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. Int Med J Malays. 2014;13(1):41–50.
6.
Zurück zum Zitat Holmes DR, Dehmer GJ, Kaul S, Leifer D, O’Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning”: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2010;56(4):321–41.PubMedCrossRef Holmes DR, Dehmer GJ, Kaul S, Leifer D, O’Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: approaches to the FDA “boxed warning”: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2010;56(4):321–41.PubMedCrossRef
7.
Zurück zum Zitat Relling M, Klein T. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89(3):464–7.PubMedPubMedCentralCrossRef Relling M, Klein T. CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network. Clin Pharmacol Ther. 2011;89(3):464–7.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Wu AH. Use of genetic and nongenetic factors in warfarin dosing algorithms. Pharmacogenomics. 2007;8(7):851–61.PubMedCrossRef Wu AH. Use of genetic and nongenetic factors in warfarin dosing algorithms. Pharmacogenomics. 2007;8(7):851–61.PubMedCrossRef
9.
Zurück zum Zitat Lesko L, Woodcock J. Pharmacogenomic-guided drug development: regulatory perspective. Pharmacogenomics J. 2002;2(1):20.PubMedCrossRef Lesko L, Woodcock J. Pharmacogenomic-guided drug development: regulatory perspective. Pharmacogenomics J. 2002;2(1):20.PubMedCrossRef
10.
Zurück zum Zitat Lesko LJ, Woodcock J. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov. 2004;3(9):763.PubMedCrossRef Lesko LJ, Woodcock J. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov. 2004;3(9):763.PubMedCrossRef
11.
Zurück zum Zitat Zineh I, Lesko LJ. Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogue. Pers Med. 2009;6(4):359–61.CrossRef Zineh I, Lesko LJ. Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogue. Pers Med. 2009;6(4):359–61.CrossRef
12.
Zurück zum Zitat Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. Life cycle of translational research for medical interventions. Science. 2008;321(5894):1.CrossRef Contopoulos-Ioannidis DG, Alexiou GA, Gouvias TC, Ioannidis JP. Life cycle of translational research for medical interventions. Science. 2008;321(5894):1.CrossRef
13.
Zurück zum Zitat Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE. Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther. 2012;92(4):467–75.PubMed Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE. Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther. 2012;92(4):467–75.PubMed
14.
15.
Zurück zum Zitat Maronde RF, Lee PV, McCarron MM, Seibert S. A study of prescribing patterns. Med Care. 1971;9(5):383–95.PubMedCrossRef Maronde RF, Lee PV, McCarron MM, Seibert S. A study of prescribing patterns. Med Care. 1971;9(5):383–95.PubMedCrossRef
16.
Zurück zum Zitat Kohn LT, Corrigan J, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000. Kohn LT, Corrigan J, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
17.
Zurück zum Zitat Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.PubMedCrossRef Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.PubMedCrossRef
18.
Zurück zum Zitat Swen J, Nijenhuis M, Boer AD, Grandia L, Maitland-van der Zee A-H, Mulder H, et al. Pharmacogenetics: from bench to byte—an update of guidelines. Pharmacol Ther. 2011;89(5):662–73.CrossRef Swen J, Nijenhuis M, Boer AD, Grandia L, Maitland-van der Zee A-H, Mulder H, et al. Pharmacogenetics: from bench to byte—an update of guidelines. Pharmacol Ther. 2011;89(5):662–73.CrossRef
19.
Zurück zum Zitat Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258.PubMedPubMedCentralCrossRef Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4):258.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Wu A, Fuhlbrigge A. Economic evaluation of pharmacogenetic tests. Clin Pharmacol Ther. 2008;84(2):272–4.PubMedCrossRef Wu A, Fuhlbrigge A. Economic evaluation of pharmacogenetic tests. Clin Pharmacol Ther. 2008;84(2):272–4.PubMedCrossRef
21.
Zurück zum Zitat Cavallari LH, Lee CR, Duarte JD, Nutescu EA, Weitzel KW, Stouffer GA, et al. Implementation of inpatient models of pharmacogenetics programs. Am J Health Syst Pharm. 2016;73(23):1944–54.PubMedCrossRef Cavallari LH, Lee CR, Duarte JD, Nutescu EA, Weitzel KW, Stouffer GA, et al. Implementation of inpatient models of pharmacogenetics programs. Am J Health Syst Pharm. 2016;73(23):1944–54.PubMedCrossRef
22.
Zurück zum Zitat Akhtar S. Pharmacogenomics: Are pharmacists ready for genotyped prescribing? Pharm J. 2002;268(7187):296–9. Akhtar S. Pharmacogenomics: Are pharmacists ready for genotyped prescribing? Pharm J. 2002;268(7187):296–9.
23.
Zurück zum Zitat Haga SB, Moaddeb J, Mills R, Patel M, Kraus W, Allen LaPointe NM. Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics. 2015;16(17):1931–41.PubMedCrossRef Haga SB, Moaddeb J, Mills R, Patel M, Kraus W, Allen LaPointe NM. Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics. 2015;16(17):1931–41.PubMedCrossRef
24.
Zurück zum Zitat El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc. 2008;48(2):e21–32.CrossRef El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc. 2008;48(2):e21–32.CrossRef
25.
Zurück zum Zitat Ferreri SP, Greco AJ, Michaels NM, O’Connor SK, Chater RW, Viera AJ, et al. Implementation of a pharmacogenomics service in a community pharmacy. J Am Pharm Assoc. 2014;54(2):172–80.CrossRef Ferreri SP, Greco AJ, Michaels NM, O’Connor SK, Chater RW, Viera AJ, et al. Implementation of a pharmacogenomics service in a community pharmacy. J Am Pharm Assoc. 2014;54(2):172–80.CrossRef
26.
Zurück zum Zitat Bright D, Kisor D, Smith A, Conaway M, Yu M. Implementation of a pharmacogenetic management service for postmyocardial infarction care in a community pharmacy. Pers Med. 2015;12(4):319–25.CrossRef Bright D, Kisor D, Smith A, Conaway M, Yu M. Implementation of a pharmacogenetic management service for postmyocardial infarction care in a community pharmacy. Pers Med. 2015;12(4):319–25.CrossRef
27.
Zurück zum Zitat Papastergiou J, Tolios P, Li W, Li J. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study. J Am Pharm Assoc. 2017;57(5):624–9.CrossRef Papastergiou J, Tolios P, Li W, Li J. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study. J Am Pharm Assoc. 2017;57(5):624–9.CrossRef
28.
Zurück zum Zitat McMahon T, Tucci J. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications. Pharm Pract. 2011;9(3):141–7. McMahon T, Tucci J. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications. Pharm Pract. 2011;9(3):141–7.
29.
Zurück zum Zitat Dias M, Ward H, Sorich M, McKinnon R. Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia. Pharmacogenomics J. 2014;14(3):235.PubMedCrossRef Dias M, Ward H, Sorich M, McKinnon R. Exploration of the perceptions, barriers and drivers of pharmacogenomics practice among hospital pharmacists in Adelaide, South Australia. Pharmacogenomics J. 2014;14(3):235.PubMedCrossRef
30.
Zurück zum Zitat Dodson C. Knowledge and attitudes concerning pharmacogenomics among healthcare professionals. Pers Med. 2011;8(4):421–8.CrossRef Dodson C. Knowledge and attitudes concerning pharmacogenomics among healthcare professionals. Pers Med. 2011;8(4):421–8.CrossRef
31.
Zurück zum Zitat Clemerson JP, Payne K, Bissell P, Anderson C. Pharmacogenetics, the next challenge for pharmacy? Pharm World Sci. 2006;28(3):126.PubMedCrossRef Clemerson JP, Payne K, Bissell P, Anderson C. Pharmacogenetics, the next challenge for pharmacy? Pharm World Sci. 2006;28(3):126.PubMedCrossRef
32.
Zurück zum Zitat Ma JD, Lee KC, Kuo GM. Clinical application of pharmacogenomics. J Pharm Pract. 2012;25(4):417–27.PubMedCrossRef Ma JD, Lee KC, Kuo GM. Clinical application of pharmacogenomics. J Pharm Pract. 2012;25(4):417–27.PubMedCrossRef
33.
Zurück zum Zitat Ventola CL. The role of pharmacogenomic biomarkers in predicting and improving drug response: part 2: challenges impeding clinical implementation. Pharm Ther. 2013;38(10):624. Ventola CL. The role of pharmacogenomic biomarkers in predicting and improving drug response: part 2: challenges impeding clinical implementation. Pharm Ther. 2013;38(10):624.
34.
Zurück zum Zitat Yau A, Aziz AB, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharm. 2015;7(3):145.CrossRef Yau A, Aziz AB, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharm. 2015;7(3):145.CrossRef
35.
Zurück zum Zitat Abdi AM, Zarouri AT, Saloumi L, Basgut B. North Cyprus pharmacist’s cognition and practice of pharmaceutical care. J Pharm Res Int. 2018;21(3):9.CrossRef Abdi AM, Zarouri AT, Saloumi L, Basgut B. North Cyprus pharmacist’s cognition and practice of pharmaceutical care. J Pharm Res Int. 2018;21(3):9.CrossRef
36.
Zurück zum Zitat Al-Baghdadi H, Al-Baghdadi ÇK, Abdi A, Gültekin O, Meštrović A, Demirdamar R, et al. Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus. Int J Clin Pharm. 2017;39(6):8.CrossRef Al-Baghdadi H, Al-Baghdadi ÇK, Abdi A, Gültekin O, Meštrović A, Demirdamar R, et al. Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus. Int J Clin Pharm. 2017;39(6):8.CrossRef
37.
Zurück zum Zitat Gökçekuş L, Mestrovic A, Basgut B. Pharmacist intervention in drug-related problems for patients with cardiovascular diseases in selected community pharmacies in Northern Cyprus. Trop J Pharm Res. 2016;15(10):2275–81.CrossRef Gökçekuş L, Mestrovic A, Basgut B. Pharmacist intervention in drug-related problems for patients with cardiovascular diseases in selected community pharmacies in Northern Cyprus. Trop J Pharm Res. 2016;15(10):2275–81.CrossRef
38.
Zurück zum Zitat Arsoy G, Varış A, Saloumi L, Abdi A, Başgut B. Insights on allergic rhinitis management from a Northern Cyprus perspective and evaluation of the impact of pharmacist-led educational intervention on patients’ outcomes. Medicina. 2018;5(54):83.CrossRef Arsoy G, Varış A, Saloumi L, Abdi A, Başgut B. Insights on allergic rhinitis management from a Northern Cyprus perspective and evaluation of the impact of pharmacist-led educational intervention on patients’ outcomes. Medicina. 2018;5(54):83.CrossRef
39.
Zurück zum Zitat Pisanu C, Tsermpini E-E, Mavroidi E, Katsila T, Patrinos GP, Squassina A. Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genom. 2014;17(5–6):272–9.CrossRef Pisanu C, Tsermpini E-E, Mavroidi E, Katsila T, Patrinos GP, Squassina A. Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genom. 2014;17(5–6):272–9.CrossRef
40.
Zurück zum Zitat Saydam F, Değirmenci İ, Birdane A, Özdemir M, Ulus T, Özbayer C, et al. The CYP2C19* 2 and CYP2C19* 17 polymorphisms play a vital role in clopidogrel responsiveness after percutaneous coronary intervention: a pharmacogenomics study. Basic Clin Pharmacol Toxicol. 2017;121(1):29–36.PubMedCrossRef Saydam F, Değirmenci İ, Birdane A, Özdemir M, Ulus T, Özbayer C, et al. The CYP2C19* 2 and CYP2C19* 17 polymorphisms play a vital role in clopidogrel responsiveness after percutaneous coronary intervention: a pharmacogenomics study. Basic Clin Pharmacol Toxicol. 2017;121(1):29–36.PubMedCrossRef
41.
Zurück zum Zitat Karaca S, Bozkurt NC, Cesuroglu T, Karaca M, Bozkurt M, Eskioglu E, et al. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events. Pharmacogenomics. 2015;16(10):1109–18.PubMedCrossRef Karaca S, Bozkurt NC, Cesuroglu T, Karaca M, Bozkurt M, Eskioglu E, et al. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events. Pharmacogenomics. 2015;16(10):1109–18.PubMedCrossRef
42.
Zurück zum Zitat Eryılmaz G, Hızlı Sayar G, Gül IG, Noyan CO, Özten E, Darçın AE, et al. Therapeutic drug monitoring: perspectives of psychiatrists in Turkey. Int J Psychiatry Clin Pract. 2015;19(1):60–4.PubMedCrossRef Eryılmaz G, Hızlı Sayar G, Gül IG, Noyan CO, Özten E, Darçın AE, et al. Therapeutic drug monitoring: perspectives of psychiatrists in Turkey. Int J Psychiatry Clin Pract. 2015;19(1):60–4.PubMedCrossRef
43.
Zurück zum Zitat Woelderink A, Ibarreta D, Hopkins M, Rodriguez-Cerezo E. The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J. 2006;6(1):3.PubMedCrossRef Woelderink A, Ibarreta D, Hopkins M, Rodriguez-Cerezo E. The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies. Pharmacogenomics J. 2006;6(1):3.PubMedCrossRef
44.
Zurück zum Zitat Keskin O, Uluca Ü, Birben E, Coşkun Y, Ozkars MY, Keskin M, et al. Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. Pediatr Allergy Immunol. 2016;27(5):507–13.PubMedCrossRef Keskin O, Uluca Ü, Birben E, Coşkun Y, Ozkars MY, Keskin M, et al. Genetic associations of the response to inhaled corticosteroids in children during an asthma exacerbation. Pediatr Allergy Immunol. 2016;27(5):507–13.PubMedCrossRef
45.
Zurück zum Zitat Hyzel C, Gok S, Sardas S, Bernard-Gallon D, Maugard C, Genç E. Personalized and predictive medicine in Turkey: a symposium report of the Istanbul Working Group on personalized medicine, Istanbul, Turkey, September 10–12, 2009. Curr Pharmacogenomics Person Med. 2009;7(4):297–301.CrossRef Hyzel C, Gok S, Sardas S, Bernard-Gallon D, Maugard C, Genç E. Personalized and predictive medicine in Turkey: a symposium report of the Istanbul Working Group on personalized medicine, Istanbul, Turkey, September 10–12, 2009. Curr Pharmacogenomics Person Med. 2009;7(4):297–301.CrossRef
46.
Zurück zum Zitat Ergoren MC, Pirzada RH, Arici M, Serakinci N. Near East University Genetic Mutation Database (NEU-GD): the first mutation database of Northern Cyprus. Gene. 2015;571(1):145–8.PubMedCrossRef Ergoren MC, Pirzada RH, Arici M, Serakinci N. Near East University Genetic Mutation Database (NEU-GD): the first mutation database of Northern Cyprus. Gene. 2015;571(1):145–8.PubMedCrossRef
47.
Zurück zum Zitat Bisgin A, Kurtaran B, Yasar HM, Tasova Y. Clinical utility of pharmacogenetic testing: current evidence of HLA-B57 positivity. Erciyes Med J. 2017;39(2):S78.CrossRef Bisgin A, Kurtaran B, Yasar HM, Tasova Y. Clinical utility of pharmacogenetic testing: current evidence of HLA-B57 positivity. Erciyes Med J. 2017;39(2):S78.CrossRef
48.
Zurück zum Zitat Cronbach LJ, Shavelson RJ. My current thoughts on coefficient alpha and successor procedures. Educ Psychol Meas. 2004;64(3):391–418.CrossRef Cronbach LJ, Shavelson RJ. My current thoughts on coefficient alpha and successor procedures. Educ Psychol Meas. 2004;64(3):391–418.CrossRef
50.
Zurück zum Zitat Hoop JG, Lapid MI, Paulson RM, Roberts LW. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 “early adopting” departments of psychiatry. J Clin Psychiatry. 2010;71(6):745–53.PubMedCrossRef Hoop JG, Lapid MI, Paulson RM, Roberts LW. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 “early adopting” departments of psychiatry. J Clin Psychiatry. 2010;71(6):745–53.PubMedCrossRef
51.
Zurück zum Zitat Hedgecoe AM. Context, ethics and pharmacogenetics. Stud Hist Philos Biol Biomed Sci. 2006;37(3):566–82.PubMedCrossRef Hedgecoe AM. Context, ethics and pharmacogenetics. Stud Hist Philos Biol Biomed Sci. 2006;37(3):566–82.PubMedCrossRef
52.
Zurück zum Zitat Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013;369(24):2283–93.PubMedPubMedCentralCrossRef Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013;369(24):2283–93.PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Pers Med. 2012;9(1):19–27.CrossRef Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Pers Med. 2012;9(1):19–27.CrossRef
54.
Zurück zum Zitat Remsberg CM, Bray BS, Wright SK, Ashmore J, Kabasenche W, Wang S, et al. Design, implementation, and assessment approaches within a pharmacogenomics course. Am J Pharm Educ. 2017;81(1):11.PubMedPubMedCentral Remsberg CM, Bray BS, Wright SK, Ashmore J, Kabasenche W, Wang S, et al. Design, implementation, and assessment approaches within a pharmacogenomics course. Am J Pharm Educ. 2017;81(1):11.PubMedPubMedCentral
55.
Zurück zum Zitat Murphy JE, Green JS, Adams LA, Squire RB, Kuo GM, McKay A. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am J Pharm Educ. 2010;74(1):7.PubMedPubMedCentralCrossRef Murphy JE, Green JS, Adams LA, Squire RB, Kuo GM, McKay A. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am J Pharm Educ. 2010;74(1):7.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Formea CM, Nicholson WT, McCullough KB, Berg KD, Berg ML, Cunningham JL, et al. Development and evaluation of a pharmacogenomics educational program for pharmacists. Am J Pharm Educ. 2013;77(1):10.PubMedPubMedCentralCrossRef Formea CM, Nicholson WT, McCullough KB, Berg KD, Berg ML, Cunningham JL, et al. Development and evaluation of a pharmacogenomics educational program for pharmacists. Am J Pharm Educ. 2013;77(1):10.PubMedPubMedCentralCrossRef
Metadaten
Titel
Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge
verfasst von
Louai Alsaloumi
Abdikarim Abdi
Özgür Tosun
Bilgen Başgut
Publikationsdatum
02.07.2019
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2019
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00868-6

Weitere Artikel der Ausgabe 5/2019

International Journal of Clinical Pharmacy 5/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.